DBV TechnologiesCHIX:DBVP 31 Market Cap is €850.51 Mil as of Jun. 27, 2026. GuruFocus rates CHIX:DBVP with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 1,431 Biotechnology companies, DBV Technologies ranks better than 80.43% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). DBV Technologies's share price for the quarter that ended in Mar. 2026 was €3.6975. DBV Technologies's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 295.91 Mil. Therefore, DBV Technologies's market cap for the quarter that ended in Mar. 2026 was €1,094.14 Mil.
DBV Technologies's quarterly market cap
increased
from Sep. 2025 (€219.45 Mil) to Dec. 2025 (€873.47 Mil) and
increased
from Dec. 2025 (€873.47 Mil) to Mar. 2026 (€1,094.14 Mil).
DBV Technologies's annual market cap
increased
from Dec. 2023 (€347.12 Mil) to Dec. 2024 (€370.11 Mil) and
increased
from Dec. 2024 (€370.11 Mil) to Dec. 2025 (€873.47 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. DBV Technologies's Enterprise Value for Today is €654.14 Mil.
DBV Technologies (CHIX:DBVp) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
DBV Technologies Market Cap Related Terms
DBV Technologies Market Cap Historical Data
* Premium members only.
The historical data trend for DBV Technologies's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:DBVP vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, DBV Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DBV Technologies Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, DBV Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where DBV Technologies's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
DBV Technologies's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DBV Technologies (CHIX:DBVP) has a Market Cap of €850.51 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DBV Technologies and its competitors. According to the industry distribution chart, DBV Technologies ranks #280 out of 1431 companies in the Biotechnology industry, placing it in the top 19.6%.
Is DBV Technologies' Market Cap too high?
DBV Technologies' current Market Cap is €850.51 Mil. Based on the distribution chart, DBV Technologies ranks #280 out of 1431 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, DBV Technologies has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does DBV Technologies' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, DBV Technologies ranks #280 out of 1431 companies for Market Cap. This places DBV Technologies in the top 20% of its industry — outperforming the majority of peers. The industry median Market Cap is 113.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DBV Technologies and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DBV Technologies's current Market Cap is €850.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DBV Technologies stock overvalued right now?
DBV Technologies (CHIX:DBVP) has a current Market Cap of €850.51 Mil. The current Market Cap is €850.51 Mil. DBV Technologies' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For DBV Technologies (CHIX:DBVP), the current Market Cap is €850.51 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
31GF Score
Get the complete analysis for CHIX:DBVP
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:DBVP has been successfully added to your 
